Researches

Displaying 51 - 60 of 4049
# Title Department Research Year
51 Design, Synthesis, and Biological Evaluation of Novel Benzimidazole/Schiff Base Hybrid Derivatives With Potential Biological Activities Department of Pharmaceutical Organic Chemistry 2025
52 Design, synthesis, and characterization of novel 5- ethylsulfonyl-indazole-3-carboxamides as dual VEGFR-2 and EGFR inhibitors: apoptotic antiproliferative and immunomodulatory evaluations Department of Pharmaceutical Organic Chemistry 2025
53 Design, synthesis, and computational studies of novel pyrazoline-based dual EGFR/HER-2 inhibitors with apoptotic antiproliferative activity Department of Pharmaceutical Organic Chemistry 2025
54 Design, synthesis, and structural elucidation of ethyl 2-amino-5-oxo-4-aryl-4H-pyrano[3,2-c] quinoline-3-carboxylates as dual EGFR/HER-2 inhibitors endowed with antiproliferative activity Department of Pharmaceutical Organic Chemistry 2025
55 Design, synthesis, antimalarial activity, and in-silico studies of new benzimidazole/pyridine hybrids as dihydrofolate reductase inhibitors Department of Pharmaceutical Organic Chemistry 2025
56 Design, synthesis, antiproliferative activity, and molecular dynamics simulation of pyrazolinebased derivatives as dual EGFR and HER-2 inhibitors Department of Pharmaceutical Organic Chemistry 2025
57 Design, synthesis, antiproliferative assessments, and computational studies of new quinolin-2(1H)-ones as dual EGFR/HER-2 inhibitors Department of Pharmaceutical Organic Chemistry 2025
58 Design, synthesis, apoptotic antiproliferative, and antioxidant activities of a new series of 2-mercaptobenzimidazole/3-cyanopyridin-2-one hybrids as dual EGFR/BRAFV600E inhibitors Department of Pharmaceutical Organic Chemistry 2025
59 Design, Synthesis, Biological Evaluation, and In Silico Studies of New Nitazoxanide Derivatives: Toward Broad‐Spectrum Antimicrobial Agents Department of Pharmaceutical Organic Chemistry 2025
60 Design, synthesis, in silico studies, and apoptotic antiproliferative activity of novel thiazole-2-acetamide derivatives as tubulin polymerization inhibitors Department of Medicinal Chemistry 2025